[Non-Classical Clinical Types and Pathological Changes of Diabetic Kidney Disease: A Review]
- PMID: 38162079
- PMCID: PMC10752793
- DOI: 10.12182/20231160102
[Non-Classical Clinical Types and Pathological Changes of Diabetic Kidney Disease: A Review]
Abstract
Diabetic kidney disease (DKD) is a common complication of diabetes mellitus and approximately 1/3 of diabetic patients may progress to DKD. A typical early clinical manifestation of DKD is microalbuminuria and patients may present with macroproteinuria accompanied by a decrease in renal function condition as the disease progresses. It is generally believed that the likelihood of a reversal of the disease is reduced after the development of macroproteinuria in patients with DKD, and that eventually some patients' condition may develop into end-stage renal disease (ESRD). Moreover, the thickening of the glomerular basement membrane, mesangial matrix expansion, Kimmelstiel-Wilson (K-W) nodules, and glomerulosclerosis in end-stage diabetes mellitus are typical pathologic changes of DKD. However, some DKD patients, especially those with type 2 diabetes mellitus (T2DM) combined with DKD, may have diverse clinical manifestations, showing variations in disease progression and regression, and manifesting as non-classical types of DKD, such as normoalbuminuric DKD, proteinuria-reduced DKD, and DKD with rapid decline in renal function. In addition, the formation of crescents, a special pathological change, is observed in renal biopsy. However, this issue is currently under-recognized by clinicians and therefore deserves more attention. In order to improve clinicians' understanding of the presentations and pathological changes of non-classical DKD and the level of DKD prevention and treatment in China, we present a preliminary introduction to the clinical phenotypes and pathological changes of non-classical types of DKD in this paper by summarizing the findings of our prior studies as well as domestic and international literature.
糖尿病肾脏疾病(diabetic kidney disease, DKD)是糖尿病的常见并发症,约1/3糖尿病患者可发展至DKD。典型DKD临床早期表现为微量蛋白尿,随着疾病进展可出现大量蛋白尿并伴随肾功能减退。一般认为DKD患者出现大量蛋白尿后病情逆转可能性降低,最终部分患者可发展为终末期肾病(end-stage renal disease, ESRD)。此外,DKD典型病理变化为肾小球基底膜增厚、系膜基质增多、K-W结节及晚期糖尿病肾小球硬化。然而,临床上某些DKD患者,特别是2型糖尿病(type 2 diabetes mellitus, T2DM)合并DKD患者临床表现可呈多样性,疾病进展与转归不同,表现为非经典型DKD类型,如正常白蛋白尿型、蛋白尿缓解型、肾功能快速下降型。此外,肾活检还可见新月体形成这一特殊病理改变。但目前临床医师对此认识尚不足,故值得重视。本文结合国内外文献及本课题组既往研究结果,对非经典DKD临床表型与病理变化进行初步介绍,以期进一步加强临床医生对非经典DKD表型与病理变化的认识,提高我国DKD防治水平。
Keywords: Albuminuria remission; Crescent; Diabetic kidney disease; Normoalbuminuria; Rapid decline in renal function; Review.
© 2023《四川大学学报(医学版)》编辑部 版权所有Copyright ©2023 Editorial Board of Journal of Sichuan University (Medical Sciences).
Conflict of interest statement
利益冲突 所有作者均声明不存在利益冲突
Similar articles
-
Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.Ren Fail. 2022 Dec;44(1):562-570. doi: 10.1080/0886022X.2022.2056053. Ren Fail. 2022. PMID: 35373711 Free PMC article.
-
Trajectories of kidney function in diabetes: a clinicopathological update.Nat Rev Nephrol. 2021 Nov;17(11):740-750. doi: 10.1038/s41581-021-00462-y. Epub 2021 Aug 6. Nat Rev Nephrol. 2021. PMID: 34363037 Review.
-
Normoalbuminuric diabetic kidney disease.Front Med. 2017 Sep;11(3):310-318. doi: 10.1007/s11684-017-0542-7. Epub 2017 Jul 18. Front Med. 2017. PMID: 28721497 Review.
-
Novel biomarkers for prognosticating diabetic kidney disease progression.Int Urol Nephrol. 2023 Apr;55(4):913-928. doi: 10.1007/s11255-022-03354-7. Epub 2022 Oct 22. Int Urol Nephrol. 2023. PMID: 36271990 Free PMC article. Review.
-
C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.J Diabetes. 2022 Apr;14(4):291-297. doi: 10.1111/1753-0407.13264. Epub 2022 Mar 24. J Diabetes. 2022. PMID: 35322566 Free PMC article.
Cited by
-
Efficacy and Safety of Low-Dose Spironolactone in Management of Diabetic Kidney Disease in a Real-World Setting.Endocrinol Diabetes Metab. 2025 Jul;8(4):e70058. doi: 10.1002/edm2.70058. Endocrinol Diabetes Metab. 2025. PMID: 40474567 Free PMC article.
References
-
- 马越, 孔祥婕, 彭雯, 等 中国糖尿病疾病负担现状及趋势. 中国预防医学杂志. 2023;24:281–286. doi: 10.16506/j.1009-6639.2023.04.001. - DOI
-
- ZOU Y, ZHAO L, ZHANG J, et al Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease. Ren Fail. 2022;44(1):562–570. doi: 10.1080/0886022x.2022.2056053. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical